[
    {
        "id": "article-131510_16",
        "title": "Surgical Options in the Treatment of Severe Obesity -- Issues of Concern -- Bariatric Procedures for Management of Severe Obesity",
        "content": "The weight loss mechanism typically falls into\u00a01 of\u00a02 categories, but some procedures have both components.\u00a0These mechanisms include malabsorption and restriction. Neurohormonal effects contribute to the regulation of energy balance and hunger control. Key hormones include leptin and ghrelin. Examples of restrictive procedures include vertical banded gastroplasty, laparoscopic adjustable gastric band, and sleeve gastrectomy. Malabsorptive procedures include jejunoileal bypass, biliopancreatic diversion (BPD), or biliopancreatic diversion with duodenal switch. A combination procedure commonly performed is the Roux-en-Y gastric bypass. [6]",
        "contents": "Surgical Options in the Treatment of Severe Obesity -- Issues of Concern -- Bariatric Procedures for Management of Severe Obesity. The weight loss mechanism typically falls into\u00a01 of\u00a02 categories, but some procedures have both components.\u00a0These mechanisms include malabsorption and restriction. Neurohormonal effects contribute to the regulation of energy balance and hunger control. Key hormones include leptin and ghrelin. Examples of restrictive procedures include vertical banded gastroplasty, laparoscopic adjustable gastric band, and sleeve gastrectomy. Malabsorptive procedures include jejunoileal bypass, biliopancreatic diversion (BPD), or biliopancreatic diversion with duodenal switch. A combination procedure commonly performed is the Roux-en-Y gastric bypass. [6]"
    },
    {
        "id": "Surgery_Schwartz_7744",
        "title": "Surgery_Schwartz",
        "content": "sur-gical risk,59 especially if the obesity is so severe that the patient cannot normally do self-care or would not likely be able to do so after surgery. In addition to excessive morbidity, the placement of these individuals in care facilities postoperatively for recovery is often impossible due to their size and limitations of physical ability. Finally, lack of sufficient social support or an extremely poor or unsupportive home environment can be contraindications to surgical care, since such environmental factors are important to optimize outcomes once discharged from the hospital.Brunicardi_Ch27_p1167-p1218.indd 117323/02/19 2:20 PM 1174SPECIFIC CONSIDERATIONSPART IIABCDEFGHFigure 27-5. Bariatric surgery procedure evolution. A. Horizontal gastroplasty; B. vertical banded gastroplasty; C. Roux-en-Y gastric bypass; D. transected Roux-en-Y gastric bypass; E. laparoscopic adjustable gastric band; F. biliopancreatic diversion; G. biliopancreatic diversion with duodenal switch; H.",
        "contents": "Surgery_Schwartz. sur-gical risk,59 especially if the obesity is so severe that the patient cannot normally do self-care or would not likely be able to do so after surgery. In addition to excessive morbidity, the placement of these individuals in care facilities postoperatively for recovery is often impossible due to their size and limitations of physical ability. Finally, lack of sufficient social support or an extremely poor or unsupportive home environment can be contraindications to surgical care, since such environmental factors are important to optimize outcomes once discharged from the hospital.Brunicardi_Ch27_p1167-p1218.indd 117323/02/19 2:20 PM 1174SPECIFIC CONSIDERATIONSPART IIABCDEFGHFigure 27-5. Bariatric surgery procedure evolution. A. Horizontal gastroplasty; B. vertical banded gastroplasty; C. Roux-en-Y gastric bypass; D. transected Roux-en-Y gastric bypass; E. laparoscopic adjustable gastric band; F. biliopancreatic diversion; G. biliopancreatic diversion with duodenal switch; H."
    },
    {
        "id": "Surgery_Schwartz_7745",
        "title": "Surgery_Schwartz",
        "content": "C. Roux-en-Y gastric bypass; D. transected Roux-en-Y gastric bypass; E. laparoscopic adjustable gastric band; F. biliopancreatic diversion; G. biliopancreatic diversion with duodenal switch; H. vertical sleeve gastrectomy. (Modified with permission from Arterburn DE, Courcoulas AP: Bariatric surgery for obesity and metabolic conditions in adults, BMJ. 2014 Aug 27;349:g3961.)Brunicardi_Ch27_p1167-p1218.indd 117423/02/19 2:20 PM 1175THE SURGICAL MANAGEMENT OF OBESITYCHAPTER 27Table 27-2Patient selection criteria for bariatric surgeryFACTORCRITERIAWeight (adults)BMI \u226540 kg/m2 with no comorbid conditionsBMI \u226535 kg/m2 with obesity-associated comorbidityWeight loss historyFailure of previous nonsurgical attempts at weight reduction, including nonprofessional programsCommitmentExpectation that patient will adhere to postoperative careFollow-up visits with physician(s) and team membersRecommended medical management, including use of dietary supplementsInstructions regarding any",
        "contents": "Surgery_Schwartz. C. Roux-en-Y gastric bypass; D. transected Roux-en-Y gastric bypass; E. laparoscopic adjustable gastric band; F. biliopancreatic diversion; G. biliopancreatic diversion with duodenal switch; H. vertical sleeve gastrectomy. (Modified with permission from Arterburn DE, Courcoulas AP: Bariatric surgery for obesity and metabolic conditions in adults, BMJ. 2014 Aug 27;349:g3961.)Brunicardi_Ch27_p1167-p1218.indd 117423/02/19 2:20 PM 1175THE SURGICAL MANAGEMENT OF OBESITYCHAPTER 27Table 27-2Patient selection criteria for bariatric surgeryFACTORCRITERIAWeight (adults)BMI \u226540 kg/m2 with no comorbid conditionsBMI \u226535 kg/m2 with obesity-associated comorbidityWeight loss historyFailure of previous nonsurgical attempts at weight reduction, including nonprofessional programsCommitmentExpectation that patient will adhere to postoperative careFollow-up visits with physician(s) and team membersRecommended medical management, including use of dietary supplementsInstructions regarding any"
    },
    {
        "id": "InternalMed_Harrison_27737",
        "title": "InternalMed_Harrison",
        "content": "FIGURE 416-2 Bariatric surgical procedures. Examples of operative interventions of vitamin B12, iron, folate, calcium, and vitamin used for surgical manipulation of the gastrointestinal tract. A. Laparoscopic adjustable D. Patients with restrictive-malabsorptive proce gastric banding. B. Laparoscopic sleeve gastrectomy. C. The Roux-en-Y gastric bypass. dures require lifelong supplementation with these D. Biliopancreatic diversion with duodenal switch. E. Biliopancreatic diversion. (From micronutrients. ML Kendrick, GF Dakin: Mayo Clin Proc 815:518, 2006; with permission.)",
        "contents": "InternalMed_Harrison. FIGURE 416-2 Bariatric surgical procedures. Examples of operative interventions of vitamin B12, iron, folate, calcium, and vitamin used for surgical manipulation of the gastrointestinal tract. A. Laparoscopic adjustable D. Patients with restrictive-malabsorptive proce gastric banding. B. Laparoscopic sleeve gastrectomy. C. The Roux-en-Y gastric bypass. dures require lifelong supplementation with these D. Biliopancreatic diversion with duodenal switch. E. Biliopancreatic diversion. (From micronutrients. ML Kendrick, GF Dakin: Mayo Clin Proc 815:518, 2006; with permission.)"
    },
    {
        "id": "article-85558_43",
        "title": "Biliopancreatic Diversion With Duodenal Switch -- Clinical Significance",
        "content": "Biliopancreatic diversion with duodenal switch is a common weight loss procedure that is gaining popularity in the US. The procedure is still not as common as sleeve gastrectomy and Roux\u00a0en-Y gastric bypass. Long-term studies have displayed similar outcomes in patients with Roux en-Y gastric bypass, sleeve gastrectomy, and biliopancreatic bypass with duodenal switch. The main differences that have been shown are that patients who are super obese with BMI greater than 50 kg/m^2 can lose more weight and maintain weight loss better than the other bariatric procedures. It has also been shown that the biliopancreatic bypass with duodenal switch has a better effect on diabetes and reduction of hyperlipidemia than the other procedures. [43] The caveat is that this procedure requires an adequate follow-up program because there is an increased risk of nutritional deficiencies compared with other bariatric procedures.",
        "contents": "Biliopancreatic Diversion With Duodenal Switch -- Clinical Significance. Biliopancreatic diversion with duodenal switch is a common weight loss procedure that is gaining popularity in the US. The procedure is still not as common as sleeve gastrectomy and Roux\u00a0en-Y gastric bypass. Long-term studies have displayed similar outcomes in patients with Roux en-Y gastric bypass, sleeve gastrectomy, and biliopancreatic bypass with duodenal switch. The main differences that have been shown are that patients who are super obese with BMI greater than 50 kg/m^2 can lose more weight and maintain weight loss better than the other bariatric procedures. It has also been shown that the biliopancreatic bypass with duodenal switch has a better effect on diabetes and reduction of hyperlipidemia than the other procedures. [43] The caveat is that this procedure requires an adequate follow-up program because there is an increased risk of nutritional deficiencies compared with other bariatric procedures."
    },
    {
        "id": "article-131510_35",
        "title": "Surgical Options in the Treatment of Severe Obesity -- Other Issues -- Primarily Revisional Procedures",
        "content": "Band revisions are utilized in patients who fail the band or have health complications requiring removal. Options for a failed band procedure can include conversion to a Roux-en-Y gastric bypass, sleeve gastrectomy, or biliopancreatic diversion with a duodenal switch. The band can also be replaced. Revisional timing is important due to inflammation or fibrosis of gastric tissue due to the band's presence. A staged approach can be utilized with the band removed, and then, after an 8-to-12-week period, the band can be converted to another bariatric procedure. [13]",
        "contents": "Surgical Options in the Treatment of Severe Obesity -- Other Issues -- Primarily Revisional Procedures. Band revisions are utilized in patients who fail the band or have health complications requiring removal. Options for a failed band procedure can include conversion to a Roux-en-Y gastric bypass, sleeve gastrectomy, or biliopancreatic diversion with a duodenal switch. The band can also be replaced. Revisional timing is important due to inflammation or fibrosis of gastric tissue due to the band's presence. A staged approach can be utilized with the band removed, and then, after an 8-to-12-week period, the band can be converted to another bariatric procedure. [13]"
    },
    {
        "id": "article-85558_17",
        "title": "Biliopancreatic Diversion With Duodenal Switch -- Indications",
        "content": "The indications for biliopancreatic diversion are mainly for bariatric procedures, with a few exceptions. The classic criteria for bariatric surgery are: Body mass index (BMI)\u00a0greater than or equal to 40 and BMI greater than or equal to 35 with at least one obesity-related comorbidity (such as diabetes mellitus, obstructive sleep apnea, hypertension, severely limiting musculoskeletal issues) Unsuccessful nonoperative weight loss treatments Mental health clearance No medical contraindications to surgery Super obese patients with BMI >50 should be considered for biliopancreatic diversion with duodenal switch [22] For patients who fail operative treatment with Roux en-Y bypass and gastric sleeve, biliopancreatic diversion with a duodenal switch should be considered [22] [23]",
        "contents": "Biliopancreatic Diversion With Duodenal Switch -- Indications. The indications for biliopancreatic diversion are mainly for bariatric procedures, with a few exceptions. The classic criteria for bariatric surgery are: Body mass index (BMI)\u00a0greater than or equal to 40 and BMI greater than or equal to 35 with at least one obesity-related comorbidity (such as diabetes mellitus, obstructive sleep apnea, hypertension, severely limiting musculoskeletal issues) Unsuccessful nonoperative weight loss treatments Mental health clearance No medical contraindications to surgery Super obese patients with BMI >50 should be considered for biliopancreatic diversion with duodenal switch [22] For patients who fail operative treatment with Roux en-Y bypass and gastric sleeve, biliopancreatic diversion with a duodenal switch should be considered [22] [23]"
    },
    {
        "id": "article-153003_14",
        "title": "Anesthetic Considerations In Bariatric Surgery -- Issues of Concern -- Types of Bariatric Surgery",
        "content": "The Roux-en-Y gastric bypass creates a small gastric pouch and anastomosis to a Roux limb of the jejunum that bypasses 75 to 150 cm of the small bowel, thereby restricting food volume at any given time and limiting absorption. Alternatively, a biliopancreatic diversion with a duodenal switch is associated with a more malabsorptive technique. The duodenal switch carries a greater risk for surgical complications but may be recommended for patients with severe obesity and diabetes. The duodenal switch reduces the size of the stomach by approximately 60% to 70% (versus 70% to 80% with a Roux-en-Y.) [16]",
        "contents": "Anesthetic Considerations In Bariatric Surgery -- Issues of Concern -- Types of Bariatric Surgery. The Roux-en-Y gastric bypass creates a small gastric pouch and anastomosis to a Roux limb of the jejunum that bypasses 75 to 150 cm of the small bowel, thereby restricting food volume at any given time and limiting absorption. Alternatively, a biliopancreatic diversion with a duodenal switch is associated with a more malabsorptive technique. The duodenal switch carries a greater risk for surgical complications but may be recommended for patients with severe obesity and diabetes. The duodenal switch reduces the size of the stomach by approximately 60% to 70% (versus 70% to 80% with a Roux-en-Y.) [16]"
    },
    {
        "id": "article-131510_53",
        "title": "Surgical Options in the Treatment of Severe Obesity -- Other Issues -- Postoperative Nutritional Management",
        "content": "In bariatric patients, laboratory evaluations of vitamins and minerals should be done annually for life.\u00a0As with Roux-en-Y gastric bypass procedures, biliopancreatic diversion with a duodenal switch can lead to dumping syndrome. Osteoporosis is seen due to the malabsorption of vitamin D and calcium. A patient can have foul-smelling stools and diarrhea with malabsorption of fat-soluble vitamins, like A, D, E, and K, and protein, fat, iron, and calcium. A potentially life-threatening diagnosis from protein malnutrition is known as kwashiorkor, which can be seen in the biliopancreatic diversion. Adding a duodenal switch with pancreatic diversion has reduced the rate of protein malabsorption from 11% to 3%. Overall, macronutrient and micronutrient goals and supplementation should be discussed and determined in the preoperative phase with a bariatric registered dietician to prevent deficiencies and subsequent symptomatology. [20]",
        "contents": "Surgical Options in the Treatment of Severe Obesity -- Other Issues -- Postoperative Nutritional Management. In bariatric patients, laboratory evaluations of vitamins and minerals should be done annually for life.\u00a0As with Roux-en-Y gastric bypass procedures, biliopancreatic diversion with a duodenal switch can lead to dumping syndrome. Osteoporosis is seen due to the malabsorption of vitamin D and calcium. A patient can have foul-smelling stools and diarrhea with malabsorption of fat-soluble vitamins, like A, D, E, and K, and protein, fat, iron, and calcium. A potentially life-threatening diagnosis from protein malnutrition is known as kwashiorkor, which can be seen in the biliopancreatic diversion. Adding a duodenal switch with pancreatic diversion has reduced the rate of protein malabsorption from 11% to 3%. Overall, macronutrient and micronutrient goals and supplementation should be discussed and determined in the preoperative phase with a bariatric registered dietician to prevent deficiencies and subsequent symptomatology. [20]"
    },
    {
        "id": "Surgery_Schwartz_8010",
        "title": "Surgery_Schwartz",
        "content": "2016;26(4):900-903. 187. Schwoerer A, Kasten K, Celio A, Pories W, Spaniolas K. The effect of close postoperative follow-up on co-morbidity improvement after bariatric surgery. Surg Obes Relat Dis. 2017;13(8):1347-1352. 188. Weichman K, Ren C, Kurian M, et al. The effectiveness of adjustable gastric banding: a retrospective 6-year U.S. follow-up study. Surg Endosc. 2011;25(2):397-403. 189. Ignat M, Vix M, Imad I, et al. Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss. Br J Surg. 2017;104(3):248-256. 190. Peterli R, Wolnerhanssen BK, Vetter D, et al. Laparoscopic sleeve gastrectomy versus roux-y-gastric bypass for morbid obesity-3-year outcomes of the prospective randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg. 2017;265(3):466-473. 191. Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg.",
        "contents": "Surgery_Schwartz. 2016;26(4):900-903. 187. Schwoerer A, Kasten K, Celio A, Pories W, Spaniolas K. The effect of close postoperative follow-up on co-morbidity improvement after bariatric surgery. Surg Obes Relat Dis. 2017;13(8):1347-1352. 188. Weichman K, Ren C, Kurian M, et al. The effectiveness of adjustable gastric banding: a retrospective 6-year U.S. follow-up study. Surg Endosc. 2011;25(2):397-403. 189. Ignat M, Vix M, Imad I, et al. Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss. Br J Surg. 2017;104(3):248-256. 190. Peterli R, Wolnerhanssen BK, Vetter D, et al. Laparoscopic sleeve gastrectomy versus roux-y-gastric bypass for morbid obesity-3-year outcomes of the prospective randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg. 2017;265(3):466-473. 191. Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg."
    },
    {
        "id": "Surgery_Schwartz_7963",
        "title": "Surgery_Schwartz",
        "content": "vertical banded gastroplasty and Roux-en-Y gastric bypass. Ann Surg. 1994;220(6):782-790. 7. Waaddegaard P, Clemmesen T, Jess P. Vertical gastric banding for morbid obesity: a long-term follow-up study. Eur J Surg. 2002;168(4):220-222.Brunicardi_Ch27_p1167-p1218.indd 120923/02/19 2:21 PM 1210SPECIFIC CONSIDERATIONSPART II 8. Balsiger BM, Poggio JL, Mai J, Kelly KA, Sarr MG. Ten and more years after vertical banded gastroplasty as pri-mary operation for morbid obesity. J Gastrointest Surg. 2000;4(6):598-605. 9. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618-620. 10. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8(3):267-282. 11. Belachew M, Legrand MJ, Defechereux TH, Burtheret MP, Jacquet N. Laparoscopic adjustable silicone gastric band-ing in the treatment of morbid obesity. A preliminary report. Surg Endosc.",
        "contents": "Surgery_Schwartz. vertical banded gastroplasty and Roux-en-Y gastric bypass. Ann Surg. 1994;220(6):782-790. 7. Waaddegaard P, Clemmesen T, Jess P. Vertical gastric banding for morbid obesity: a long-term follow-up study. Eur J Surg. 2002;168(4):220-222.Brunicardi_Ch27_p1167-p1218.indd 120923/02/19 2:21 PM 1210SPECIFIC CONSIDERATIONSPART II 8. Balsiger BM, Poggio JL, Mai J, Kelly KA, Sarr MG. Ten and more years after vertical banded gastroplasty as pri-mary operation for morbid obesity. J Gastrointest Surg. 2000;4(6):598-605. 9. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618-620. 10. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8(3):267-282. 11. Belachew M, Legrand MJ, Defechereux TH, Burtheret MP, Jacquet N. Laparoscopic adjustable silicone gastric band-ing in the treatment of morbid obesity. A preliminary report. Surg Endosc."
    },
    {
        "id": "Surgery_Schwartz_7844",
        "title": "Surgery_Schwartz",
        "content": "B12 annually (methylmalonic acid and homocysteine optional) then every 3\u20136 months if supplementedYesYesYesYesFolic acid (red blood cell folic acid optional), iron studies, vitamin D, intact parathyroid hormoneNoNoYesYesVitamin A initially and every 6\u201312 months thereafterNoNoOptionalYesCopper, zinc, and selenium evaluation with specific findingsNoNoYesYesThiamine evaluation with specific findingsYesYesYesYesaDXA = dual energy X-ray absorptiometry; LAGB = laparoscopic adjustable gastric banding; SG = sleeve gastrectomy; LRYGB = laparoscopic Roux-en-Y gastric bypass; BPD/DS = biliopancreatic diversion with duodenal switch.Data from Mechanick JI, Youdim A, Jones DB, et al: Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient\u20142013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery, Obesity (Silver Spring). 2013",
        "contents": "Surgery_Schwartz. B12 annually (methylmalonic acid and homocysteine optional) then every 3\u20136 months if supplementedYesYesYesYesFolic acid (red blood cell folic acid optional), iron studies, vitamin D, intact parathyroid hormoneNoNoYesYesVitamin A initially and every 6\u201312 months thereafterNoNoOptionalYesCopper, zinc, and selenium evaluation with specific findingsNoNoYesYesThiamine evaluation with specific findingsYesYesYesYesaDXA = dual energy X-ray absorptiometry; LAGB = laparoscopic adjustable gastric banding; SG = sleeve gastrectomy; LRYGB = laparoscopic Roux-en-Y gastric bypass; BPD/DS = biliopancreatic diversion with duodenal switch.Data from Mechanick JI, Youdim A, Jones DB, et al: Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient\u20142013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery, Obesity (Silver Spring). 2013"
    },
    {
        "id": "Pharmacology_Katzung_4760",
        "title": "Pharmacology_Katzung",
        "content": "B. Type 2 Diabetes Normalization of glucose levels can occur with weight loss and improved insulin sensitivity in the obese patient with type 2 diabetes. A combination of caloric restriction and increased exercise is necessary if a weight reduction program is to be successful. Understanding the long-term consequences of poorly controlled diabetes may motivate some patients to lose weight. For selected patients, medical or surgical options should be considered. Orlistat, phentermine/ topiramate, lorcaserin, naltrexone plus extended release bupropion, and high-dose liraglutide are approved weight loss medications for use in combination with diet and exercise. Bariatric surgery (Roux-en-Y, gastric banding, gastric sleeve, biliopancreatic diversion/duodenal switch) typically result in significant weight loss and can result in remission of the diabetes.",
        "contents": "Pharmacology_Katzung. B. Type 2 Diabetes Normalization of glucose levels can occur with weight loss and improved insulin sensitivity in the obese patient with type 2 diabetes. A combination of caloric restriction and increased exercise is necessary if a weight reduction program is to be successful. Understanding the long-term consequences of poorly controlled diabetes may motivate some patients to lose weight. For selected patients, medical or surgical options should be considered. Orlistat, phentermine/ topiramate, lorcaserin, naltrexone plus extended release bupropion, and high-dose liraglutide are approved weight loss medications for use in combination with diet and exercise. Bariatric surgery (Roux-en-Y, gastric banding, gastric sleeve, biliopancreatic diversion/duodenal switch) typically result in significant weight loss and can result in remission of the diabetes."
    },
    {
        "id": "article-35329_4",
        "title": "Postoperative Assessment and Management of Obesity Surgery -- Technique or Treatment -- Surgical Obesity Treatment",
        "content": "There are different\u00a0types of surgical obesity treatment: malabsorptive and restrictive procedures and a combination of both. Malabsorptive surgeries prevent the absorption of food and restrict work by reducing the volume of food intake due to early satiety. [3] The\u00a04 most commonly performed bariatric surgeries include the adjustable gastric band (AGB), sleeve gastrectomy (SG), Roux-en-y gastric bypass (RYGB), and the biliopancreatic diversion (BPD), also known as the duodenal switch (DS).",
        "contents": "Postoperative Assessment and Management of Obesity Surgery -- Technique or Treatment -- Surgical Obesity Treatment. There are different\u00a0types of surgical obesity treatment: malabsorptive and restrictive procedures and a combination of both. Malabsorptive surgeries prevent the absorption of food and restrict work by reducing the volume of food intake due to early satiety. [3] The\u00a04 most commonly performed bariatric surgeries include the adjustable gastric band (AGB), sleeve gastrectomy (SG), Roux-en-y gastric bypass (RYGB), and the biliopancreatic diversion (BPD), also known as the duodenal switch (DS)."
    },
    {
        "id": "article-85558_4",
        "title": "Biliopancreatic Diversion With Duodenal Switch -- Introduction",
        "content": "Bariatric surgery is an effective modality that can maintain weight loss and decrease obesity-associated comorbid conditions. Obesity is related to the development of comorbidities such as type 2\u00a0diabetes, heart disease, hypertension, sleep apnea, and different orthopedic disabilities. Common bariatric surgical procedures that are completed today are the sleeve gastrectomy, Roux en-Y gastric bypass, and the biliopancreatic diversion with duodenal switch. The Biliopancreatic diversion was first described by Scorpinaro in 1979. This procedure combined a horizontal gastric resection with the closure of a duodenal stump, gastroileal anastomosis, and an ileoileal anastomosis, to create a 50-cm common channel and a 250-cm alimentary channel. [2]",
        "contents": "Biliopancreatic Diversion With Duodenal Switch -- Introduction. Bariatric surgery is an effective modality that can maintain weight loss and decrease obesity-associated comorbid conditions. Obesity is related to the development of comorbidities such as type 2\u00a0diabetes, heart disease, hypertension, sleep apnea, and different orthopedic disabilities. Common bariatric surgical procedures that are completed today are the sleeve gastrectomy, Roux en-Y gastric bypass, and the biliopancreatic diversion with duodenal switch. The Biliopancreatic diversion was first described by Scorpinaro in 1979. This procedure combined a horizontal gastric resection with the closure of a duodenal stump, gastroileal anastomosis, and an ileoileal anastomosis, to create a 50-cm common channel and a 250-cm alimentary channel. [2]"
    }
]